Cargando…

The Regulation of NFE2L2 (NRF2) Signalling and Epithelial-to-Mesenchymal Transition in Age-Related Macular Degeneration Pathology

Age-related macular degeneration (AMD) is a mounting cause of loss of sight in the elderly in the developed countries, a trend enhanced by the continual ageing of the population. AMD is a multifactorial and only partly understood, malady. Unfortunately, there is no effective treatment for most AMD p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hyttinen, Juha M. T., Kannan, Ram, Felszeghy, Szabolcs, Niittykoski, Minna, Salminen, Antero, Kaarniranta, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888570/
https://www.ncbi.nlm.nih.gov/pubmed/31752195
http://dx.doi.org/10.3390/ijms20225800
_version_ 1783475261436592128
author Hyttinen, Juha M. T.
Kannan, Ram
Felszeghy, Szabolcs
Niittykoski, Minna
Salminen, Antero
Kaarniranta, Kai
author_facet Hyttinen, Juha M. T.
Kannan, Ram
Felszeghy, Szabolcs
Niittykoski, Minna
Salminen, Antero
Kaarniranta, Kai
author_sort Hyttinen, Juha M. T.
collection PubMed
description Age-related macular degeneration (AMD) is a mounting cause of loss of sight in the elderly in the developed countries, a trend enhanced by the continual ageing of the population. AMD is a multifactorial and only partly understood, malady. Unfortunately, there is no effective treatment for most AMD patients. It is known that oxidative stress (OS) damages the retinal pigment epithelium (RPE) and contributes to the progression of AMD. We review here the potential importance of two OS-related cellular systems in relation to AMD. First, the nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2)-mediated OS response signalling pathway is important in the prevention of oxidative damage and a failure of this system could be critical in the development of AMD. Second, epithelial-to-mesenchymal transition (EMT) represents a change in the cellular phenotype, which ultimately leads to the fibrosis encountered in RPE, a characteristic of AMD. Many of the pathways triggering EMT are promoted by OS. The possible interconnections between these two signalling routes are discussed here. From a broader perspective, the control of NFE2L2 and EMT as ways of preventing OS-derived cellular damage could be potentially valuable in the therapy of AMD.
format Online
Article
Text
id pubmed-6888570
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-68885702019-12-09 The Regulation of NFE2L2 (NRF2) Signalling and Epithelial-to-Mesenchymal Transition in Age-Related Macular Degeneration Pathology Hyttinen, Juha M. T. Kannan, Ram Felszeghy, Szabolcs Niittykoski, Minna Salminen, Antero Kaarniranta, Kai Int J Mol Sci Review Age-related macular degeneration (AMD) is a mounting cause of loss of sight in the elderly in the developed countries, a trend enhanced by the continual ageing of the population. AMD is a multifactorial and only partly understood, malady. Unfortunately, there is no effective treatment for most AMD patients. It is known that oxidative stress (OS) damages the retinal pigment epithelium (RPE) and contributes to the progression of AMD. We review here the potential importance of two OS-related cellular systems in relation to AMD. First, the nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2)-mediated OS response signalling pathway is important in the prevention of oxidative damage and a failure of this system could be critical in the development of AMD. Second, epithelial-to-mesenchymal transition (EMT) represents a change in the cellular phenotype, which ultimately leads to the fibrosis encountered in RPE, a characteristic of AMD. Many of the pathways triggering EMT are promoted by OS. The possible interconnections between these two signalling routes are discussed here. From a broader perspective, the control of NFE2L2 and EMT as ways of preventing OS-derived cellular damage could be potentially valuable in the therapy of AMD. MDPI 2019-11-18 /pmc/articles/PMC6888570/ /pubmed/31752195 http://dx.doi.org/10.3390/ijms20225800 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Hyttinen, Juha M. T.
Kannan, Ram
Felszeghy, Szabolcs
Niittykoski, Minna
Salminen, Antero
Kaarniranta, Kai
The Regulation of NFE2L2 (NRF2) Signalling and Epithelial-to-Mesenchymal Transition in Age-Related Macular Degeneration Pathology
title The Regulation of NFE2L2 (NRF2) Signalling and Epithelial-to-Mesenchymal Transition in Age-Related Macular Degeneration Pathology
title_full The Regulation of NFE2L2 (NRF2) Signalling and Epithelial-to-Mesenchymal Transition in Age-Related Macular Degeneration Pathology
title_fullStr The Regulation of NFE2L2 (NRF2) Signalling and Epithelial-to-Mesenchymal Transition in Age-Related Macular Degeneration Pathology
title_full_unstemmed The Regulation of NFE2L2 (NRF2) Signalling and Epithelial-to-Mesenchymal Transition in Age-Related Macular Degeneration Pathology
title_short The Regulation of NFE2L2 (NRF2) Signalling and Epithelial-to-Mesenchymal Transition in Age-Related Macular Degeneration Pathology
title_sort regulation of nfe2l2 (nrf2) signalling and epithelial-to-mesenchymal transition in age-related macular degeneration pathology
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888570/
https://www.ncbi.nlm.nih.gov/pubmed/31752195
http://dx.doi.org/10.3390/ijms20225800
work_keys_str_mv AT hyttinenjuhamt theregulationofnfe2l2nrf2signallingandepithelialtomesenchymaltransitioninagerelatedmaculardegenerationpathology
AT kannanram theregulationofnfe2l2nrf2signallingandepithelialtomesenchymaltransitioninagerelatedmaculardegenerationpathology
AT felszeghyszabolcs theregulationofnfe2l2nrf2signallingandepithelialtomesenchymaltransitioninagerelatedmaculardegenerationpathology
AT niittykoskiminna theregulationofnfe2l2nrf2signallingandepithelialtomesenchymaltransitioninagerelatedmaculardegenerationpathology
AT salminenantero theregulationofnfe2l2nrf2signallingandepithelialtomesenchymaltransitioninagerelatedmaculardegenerationpathology
AT kaarnirantakai theregulationofnfe2l2nrf2signallingandepithelialtomesenchymaltransitioninagerelatedmaculardegenerationpathology
AT hyttinenjuhamt regulationofnfe2l2nrf2signallingandepithelialtomesenchymaltransitioninagerelatedmaculardegenerationpathology
AT kannanram regulationofnfe2l2nrf2signallingandepithelialtomesenchymaltransitioninagerelatedmaculardegenerationpathology
AT felszeghyszabolcs regulationofnfe2l2nrf2signallingandepithelialtomesenchymaltransitioninagerelatedmaculardegenerationpathology
AT niittykoskiminna regulationofnfe2l2nrf2signallingandepithelialtomesenchymaltransitioninagerelatedmaculardegenerationpathology
AT salminenantero regulationofnfe2l2nrf2signallingandepithelialtomesenchymaltransitioninagerelatedmaculardegenerationpathology
AT kaarnirantakai regulationofnfe2l2nrf2signallingandepithelialtomesenchymaltransitioninagerelatedmaculardegenerationpathology